LUPS-Lipids and Glucose Under Prospective Surveillance

Prospective, non-randomized cohort study to analyse genetic variations, dietary patterns, perceived stress and anxiety and early changes in lipid metabolism leading to the metabolic syndrome and type 2 diabetes

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Syndrome Angina Pectoris Cardiovascular Diseases Diabetes Mellitus Diabetes Mellitus, Type 2 Endocrine System Diseases Glucose Metabolism Disorders Heart Diseases Hyperinsulinism Insulin Resistance Metabolic Diseases Microvascular Angina Myocardial Ischemia Nutritional and Metabolic Diseases Type 2 Diabetes Vascular Diseases

Age range

25 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Asklepios Klinik St.Georg, Hamburg, Germany

About this study

The LUPS-study is a collaboration between Asklepios Clinics Hamburg GmbH and University Clinic Hamburg Eppendorf, Germany. This study is assessing a multitude of serum biomarkers, anthropometrics, dietary habits, physical activity, perceived stress along with genetic information from "healthy workers" (25-60years) to better understand phenotype-genotype associations leading to MetS and type 2 diabetes.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

25-60 years men and women willing to give consent

Exclusion criteria

diabetes (type 1 or 2)

Treatment and study plan

Primary outcomes

Metabolic Syndrome, Type 2 Diabetes

Time frame: 10 years

assessing risk factors, e.g. HDL, BMI, Blood Pressure, FPG

Sponsors and collaborators

Lead sponsor

Asklepios proresearch

Industry

Collaborators

City of Hamburg
Universitätsklinikum Hamburg-Eppendorf

Registry information

Official study title

Lipids and Glucose Under Prospective Surveillance

Acronym: LUPS

Important dates

Study start: 2008
Primary completion: 2019
Study completion: 2019
First posted: Mar 11, 2011
Registry last updated: Aug 9, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed